COVID-19 Increases Morbidity and Mortality in Myeloma Patients: One Third of Hospitalized Myeloma Patients Die Because of SARS-CoV-2
Vaccination against SARS-CoV-2: Suboptimal Response in Myeloma Patients Under Therapy
Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.